Search research articles
Contact Us
Filters
Showing results (21-30 of 888) with videos related to
Page
of 89
Sort By:
The British Journal of Dermatology
|
March 29, 2022
Raising the bar for efficacy in hidradenitis suppurativa: a rationale for combination targeted therapies
Amit Garg, James G Krueger
Advances in Dermatology
|
January 17, 2003
Treatment of inflammatory dermatoses with novel biologic agents: a primer
Rachel Nussbaum, James G Krueger
Journal of the American Academy of Dermatology
|
May 22, 2004
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
Christopher S Carlin, Steven R Feldman, James G Krueger, et al.
Annual Review of Medicine
|
October 1, 2016
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis
Jaehwan Kim, James G Krueger
The Journal of Investigative Dermatology
|
June 1, 1984
Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin
G G Krueger, M Emam
Archives of Dermatology
|
February 1, 1990
Attraction of MD-PhDs to dermatology
G Krueger, J J Leyden
The Journal of Investigative Dermatology
|
June 1, 1994
Epidemiology of psoriasis: clinical issues
G G Krueger, M Duvic
Dermatologic Clinics
|
November 22, 2014
The immunopathogenesis of psoriasis
Jaehwan Kim, James G Krueger
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
June 1, 1985
Application of a unique monoclonal antibody as a marker for nonproliferating subpopulations of cells of some tissue
E Wang, J G Krueger
The Journal of Investigative Dermatology
|
June 1, 1981
Biology of human skin transplanted to the nude mouse: I. Response to agents which modify epidermal proliferation
G G Krueger, J Shelby
Page
of 89
Search research articles
Search
Showing results (21-30 of 888) with videos related to
Sort By:
Page
of 89
The British Journal of Dermatology
|
March 29, 2022
Raising the bar for efficacy in hidradenitis suppurativa: a rationale for combination targeted therapies
Amit Garg, James G Krueger
Advances in Dermatology
|
January 17, 2003
Treatment of inflammatory dermatoses with novel biologic agents: a primer
Rachel Nussbaum, James G Krueger
Journal of the American Academy of Dermatology
|
May 22, 2004
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis
Christopher S Carlin, Steven R Feldman, James G Krueger, et al.
Annual Review of Medicine
|
October 1, 2016
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis
Jaehwan Kim, James G Krueger
The Journal of Investigative Dermatology
|
June 1, 1984
Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin
G G Krueger, M Emam
Archives of Dermatology
|
February 1, 1990
Attraction of MD-PhDs to dermatology
G Krueger, J J Leyden
The Journal of Investigative Dermatology
|
June 1, 1994
Epidemiology of psoriasis: clinical issues
G G Krueger, M Duvic
Dermatologic Clinics
|
November 22, 2014
The immunopathogenesis of psoriasis
Jaehwan Kim, James G Krueger
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
June 1, 1985
Application of a unique monoclonal antibody as a marker for nonproliferating subpopulations of cells of some tissue
E Wang, J G Krueger
The Journal of Investigative Dermatology
|
June 1, 1981
Biology of human skin transplanted to the nude mouse: I. Response to agents which modify epidermal proliferation
G G Krueger, J Shelby
Page
of 89